Transdermal buprenorphine patch: Potential for role in management of opioid dependence.
作者： Anju Dhawan , Tamonud Modak , Siddharth Sarkar , None
DOI: 10.1016/J.AJP.2019.02.002
关键词:
摘要: Despite proven clinical utility, use of sublinugual buprenorphine is fraught with issues potential diversion among patients opioid dependence. Transdermal patches provide an alternative delivery model that can be utilized to reduce such diversion. This narrative review discusses the transdermal formulations, and its pharmacology, drug interaction tolerability profile. The studies utilizing in treatment dependence are examined, while using for maintenance examined.
sci-hub.se 参考文章(34)
Elinore F. McCance-Katz, Lynn E. Sullivan, Srikanth Nallani, Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review American Journal on Addictions. ,vol. 19, pp. 4- 16 ,(2010) , 10.1111/J.1521-0391.2009.00005.X
Joseph P Kitzmiller, Christopher J Barnett, Nathan S Steiner, Nicoleta Stoicea, Nawal Kamar, Jasmine A Luzum, Eduard Mikulik, Sergio D Bergese, Buprenorphine: revisiting the efficacy of transdermal delivery system Therapeutic Delivery. ,vol. 6, pp. 419- 422 ,(2015) , 10.4155/TDE.15.3
Warren Wen, Shau Yu Lynch, Catherine Munera, Ruth Swanton, Steven R Ripa, Howard Maibach, Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis. Expert Opinion on Drug Safety. ,vol. 12, pp. 309- 319 ,(2013) , 10.1517/14740338.2013.780025
Rebecca A. Jenkinson, Nicolas C. Clark, Craig L. Fry, Malcolm Dobbin, Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction. ,vol. 100, pp. 197- 205 ,(2005) , 10.1111/J.1360-0443.2004.00958.X
John Mendelson, Robert A. Upton, E. Thomas Everhart, Peyton Jacob III, Reese T. Jones, Bioavailability of Sublingual Buprenorphine The Journal of Clinical Pharmacology. ,vol. 37, pp. 31- 37 ,(1997) , 10.1177/009127009703700106
Rajneesh P. Nath, Robert A. Upton, E. Thomas Everhart, Polly Cheung, Peter Shwonek, Reese T. Jones, John E. Mendelson, Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations The Journal of Clinical Pharmacology. ,vol. 39, pp. 619- 623 ,(1999) , 10.1177/00912709922008236
Jörg Filitz, Norbert Griessinger, Reinhard Sittl, Rudi Likar, Jürgen Schüttler, Wolfgang Koppert, Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine European Journal of Pain. ,vol. 10, pp. 743- 743 ,(2006) , 10.1016/J.EJPAIN.2005.12.001
Paul J Whelan, Kimberly Remski, Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds. Journal of Neurosciences in Rural Practice. ,vol. 3, pp. 45- 50 ,(2012) , 10.4103/0976-3147.91934
Elinore F. McCance-Katz, David E. Moody, Sudha Prathikanti, Gerald Friedland, Petrie M. Rainey, Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients Drug and Alcohol Dependence. ,vol. 118, pp. 326- 334 ,(2011) , 10.1016/J.DRUGALCDEP.2011.04.013
W. Wen, S. Lynch, C. Munera, S. Ripa, R. Swanton, The adverse event profile of Butrans™ (buprenorphine) transdermal system in patients ≥ 65 and < 65 years of age The Journal of Pain. ,vol. 12, pp. 63- ,(2011) , 10.1016/J.JPAIN.2011.02.254